GA

Graham P. Allaway

PP Progenics Pharmaceuticals: 16 patents #3 of 53Top 6%
PP Panacos Pharmaceuticals: 4 patents #2 of 14Top 15%
UH University Of North Carolina At Chapel Hill: 2 patents #408 of 1,688Top 25%
MY Myrexis: 1 patents #13 of 44Top 30%
US US Dept of Health & Human Services: 1 patents #1,144 of 3,044Top 40%
📍 Potsdam, NY: #14 of 231 inventorsTop 7%
🗺 New York: #6,536 of 115,490 inventorsTop 6%
Overall (All Time): #210,812 of 4,157,543Top 6%
21
Patents All Time

Issued Patents All Time

Showing 1–21 of 21 patents

Patent #TitleCo-InventorsDate
8318425 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein Karl Salzwedel, Feng Li, Carl T. Wild, Eric O. Freed 2012-11-27
7935797 CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion Virginia M. Litwin, Paul J. Maddon, William Olson 2011-05-03
7901685 Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion Virginia M. Litwin, Paul J. Maddon 2011-03-08
7862994 Methods for inhibiting HIV-1 envelope glycoprotein-medicated membrane fusion Virginia M. Litwin, Paul J. Maddon 2011-01-04
7858298 Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists Virginia M. Litwin, Paul J. Maddon, William Olson 2010-12-28
7537765 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein Karl Salzwedel, Feng Li, Carl T. Wild, Eric O. Freed 2009-05-26
7365221 Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof Carl T. Wild, Yoshiki Kashiwada, Kuo-Hsiung Lee 2008-04-29
7345153 Compounds capable of inhibiting HIV-1 infection Virginia M. Litwin, Paul J. Maddon 2008-03-18
7118859 Methods for inhibiting HIV-1 infection Virginia M. Litwin, Paul J. Maddon 2006-10-10
6972126 Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing same Virginia M. Litwin, Paul J. Maddon 2005-12-06
6768007 Substituted 3′,4′-di-O-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and methods for using thereof Kuo-Hsiung Lee, Lan Xie, Carl T. Wild 2004-07-27
6737267 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof Paul J. Maddon 2004-05-18
6605427 Assay for detection of viral fusion inhibitors Carl T. Wild 2003-08-12
6344545 Method for preventing HIV-1 infection of CD4+ cells Virginia M. Litwin, Paul J. Maddon, William Olson 2002-02-05
6342586 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates and uses thereof Paul J. Maddon 2002-01-29
6261763 Fluorescence resonance energy transfer screening assay for the identification of compounds that are capable of abrogating macrophage-tropic HIV-1 cell fusion Virginia M. Litwin, Paul J. Maddon 2001-07-17
6177549 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof Paul J. Maddon 2001-01-23
6107019 Method for preventing HIV-1 infection of CD4.sup.+ cells Virginia M. Litwin, Paul J. Maddon, William Olson 2000-08-22
6083478 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 Immunoconjugates, and uses thereof Paul J. Maddon 2000-07-04
6034223 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof Paul J. Maddon 2000-03-07
5817767 Synergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using same Paul J. Maddon 1998-10-06